AOM Infusion
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AOM Infusion - overview
Established
1994
Location
Fort Worth, TX, US
Primary Industry
Healthcare
About
Based in Texas, US, and founded in 1994 by its CEO Sam Jampolis, AOM Infusion, formerly known as American Outcomes Management, L. P. , operates as a provider of home infusion and intravenous immunoglobulin therapy services to patients with chronic and acute disease conditions. In March 2025, Revelstoke Capital Partners invested in AOM Infusion as part of recapitalisation.
Financial terms were not disclosed. As of March 2022, the company holds pharmacy licenses in 50 states including New York City, Delray Beach, Florida and Fort Worth, and Texas and administers 2,300 therapies monthly. American Outcomes Management, L. P.
offers infusion services and support including Infusion Therapy; Pharmacy Services, that develop a treatment plan; Referral Management, Insurance Verification, Skilled Infusion Nursing Care, Complete Patient Education, and Training. It also offers a variety of home infusion IV therapy services specializing in the care of patients with chronic and acute disease conditions conducted in the comfort of the patient home and at a time that is convenient for scheduling. Following the acquisition, American Outcomes Management, L. P.
plans to expand its footprint globally and to continue to grow into new markets.
Current Investors
Ridgemont Equity Partners, Revelstoke Capital Partners
Primary Industry
Healthcare
Sub Industries
Education & Training Services, Home Healthcare, Nursing Homes & Assisted Living
Website
www.aominfusionrx.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
AOM Infusion - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recapitalisation | Completed | AOM Infusion | - | ||||||||
| Buyout | Completed | AOM Infusion | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.